Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThe three licensed injection sites for Wegovy are the abdomen, the front of the thigh, and the upper arm — each delivers the medicine subcutaneously and all are clinically equivalent in terms of absorption. Rotating between them every week matters more than picking a single favourite. Wegovy is a prescription-only medicine; a GPhC-registered prescriber assesses whether it is appropriate for you before any treatment begins. Here is what the clinical evidence and manufacturer guidance say about choosing and preparing your site.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
In short: no, not meaningfully. The Wegovy SmPC (the definitive prescribing document held on the Electronic Medicines Compendium) states that subcutaneous semaglutide can be injected into the abdomen, front of the thigh, or the upper arm, and that absorption is considered clinically comparable across all three. The medicine reaches the same circulation regardless of which site you use.
That said, most people find the abdomen the easiest site to manage on their own. The skin there tends to be pinchable without help, the injection angle is straightforward, and you can see what you are doing. The thigh is a solid alternative if you prefer to sit down. The upper arm, by contrast, is harder to inject without a second person steadying the pen, it is better suited to weeks when a partner or carer can assist.
The practical rule is this: pick the site that is most comfortable for you each week and alternate. Comfort leads to consistency, and consistency matters far more than chasing a marginal site preference. For a broader look at how to make treatment work alongside lifestyle changes, the guide to using Wegovy effectively covers preparation and technique in more depth.
Injecting repeatedly into exactly the same small patch of skin causes a reaction called lipohypertrophy, a build-up of fatty tissue under the skin that can actually slow or unpredictably alter how the medicine is absorbed. It can also leave the area permanently lumpy. The solution is straightforward: rotate.
Rotation works on two levels. First, alternate the main body area each week, abdomen one week, thigh the next, upper arm the week after, then back to the abdomen. Second, within each area, move at least 1–2 cm from last week's exact spot. Think of dividing the abdomen into a loose grid and working around it rather than returning to the same point. The step-by-step site guide walks through this grid approach in practical terms.
The NHS patient information for semaglutide, available on NHS.uk, reinforces this rotation principle and advises keeping a simple note of where you injected last time, easy enough, even if you just jot it on your phone after the jab. Avoid injecting into any skin that looks red, bruised, tender or thickened. If you notice a lump that persists between doses, mention it at your next prescriber review.
Yes. Regardless of which of the three main areas you use, certain spots within them are off-limits. The Wegovy Patient Information Leaflet and the SmPC both specify that you should not inject into skin with stretch marks, scarring, tattoos, or varicose veins directly beneath. Broken or recently sunburned skin is also excluded, it changes absorption and increases the risk of irritation.
Within the abdomen specifically, a 5 cm radius around the navel should be avoided. This matters for a lot of people who naturally gravitate towards the centre of the stomach because it feels easiest to pinch; shifting just a few centimetres to the side changes that.
Injection-site reactions (mild redness, a small lump, brief stinging) are common and usually settle within a day or two, as noted in the NHS semaglutide medicines information. Persistent, spreading redness or pain that does not settle warrants a conversation with your prescriber or GP. If you are using alcohol swabs to clean the skin beforehand, let the area dry fully before inserting the needle, injecting through wet skin stings unnecessarily.
This is a question our prescribers hear fairly regularly, and the honest answer is that any pharmacokinetic differences between sites are small enough to be clinically insignificant for most people. Semaglutide's half-life is approximately one week, it accumulates steadily over several weeks regardless of where each dose lands, and you can read more about which injection spot tends to work best for different people if you want to explore the detail behind that consistency. The practical implication: you will not feel Wegovy working faster by always choosing the abdomen over the thigh.
What does change the experience is technique, slow, steady insertion at the correct angle (the pen handles this automatically), holding the pen in place until the injection is complete, and waiting a few seconds before removing it. These steps make a bigger difference to comfort than site selection. Curiosity about which injection site suits different lifestyles is entirely reasonable; the answer is nearly always the one you can do calmly and confidently each week.
Wegovy is a prescription-only medicine, and the cost of treatment is worth understanding before you start, the Wegovy pricing and access guide sets out what private treatment typically involves in the UK. It is also worth knowing what happens if your Wegovy pen accidentally freezes, since correct storage is an easy thing to overlook but can affect your dose. When you are ready to find out whether it is clinically suitable for you, a consultation with our prescribers is the starting point.
If you have any questions about site technique or your treatment plan, our aftercare team is available seven days a week. Speak to our prescribers to begin your free consultation and get a clear clinical picture of whether Wegovy is right for you.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.